Reduced expression of indoleamine 2,3-dioxygenase participates in pathogenesis of preeclampsia via regulatory T cells

Molecular Medicine Reports

Volumn 4, Issue 1, 2011, Pages 53-58

  Liu, Xiaoqian ^a   Liu, Yanxia ^a   Ding, Mei ^a   Wang, Xin ^a,b  

^a SHANDONG UNIVERSITY   (China)

^b SHANDONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

Forkhead box P3; Indoleamine 2,3 dioxygenase; Interleukin 18; Preeclampsia; Regulatory T cells

Indexed keywords

INDOLEAMINE 2,3 DIOXYGENASE; INTERLEUKIN 18; TRANSCRIPTION FACTOR FOXP3;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CORRELATION ANALYSIS; FEMALE; GESTATIONAL AGE; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PATHOGENESIS; PLACENTA; PREECLAMPSIA; PROTEIN ANALYSIS; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REGULATORY T LYMPHOCYTE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADULT; DOWN-REGULATION; FEMALE; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION; HUMANS; IMMUNOHISTOCHEMISTRY; INDOLEAMINE-PYRROLE 2,3,-DIOXYGENASE; INTERLEUKIN-18; PLACENTA; PRE-ECLAMPSIA; PREGNANCY; RNA, MESSENGER; T-LYMPHOCYTES, REGULATORY;

EID: 78651410775     PISSN: 17912997     EISSN: 17913004     Source Type: Journal    
DOI: 10.3892/mmr.2010.395     Document Type: Article

References (31)

1. Williams DJ and De Swiet M: The pathophysiology of preeclampsia. Intensive Care Med 23: 620-629, 1997.
2. Van Beek E and Peeters LL: Pathogenesis of preeclampsia: a comprehensive model. Obstet Gynecol Surv 53: 233-239, 1998.
3. Sibai B, Dekker G and Kupferminc M: Preeclampsia. Lancet 365: 785-799, 2005.
4. Redman CW and Sargent IL: Latest advances in understanding preeclampsia. Science 308: 1592-1594, 2005.
5. Nishizawa H, Hasegawa K, Suzuki M, et al: The etiological role of allogeneic fetal rejection in preeclampsia. Am J Reprod Immunol 58: 11-20, 2007.
6. Santoso DIS, Rogers P, Wallacea EM, Manuelpillaia U, Walkerb D and Subakir SB: Localization of indoleamine 2,3-dioxygenase and 4-hydroxynonenal in normal and preeclamptic placentae. Placenta 23: 373-379, 2002.
7. Steinborn A, Haensch GM, Mahnke K, et al: Distinct subsets of regulatory T cells during pregnancy: is the imbalance of these subsets involved in the pathogenesis of preeclampsia? Clin Immunol 129: 401-412, 2008.
8. Sasaki Y, Darmochwal-Kolarz D, Suzuki D, et al: Proportion of peripheral blood and decidual CD4(+) CD25(bright) regulatory T cells in Preeclampsia. Clin Exp Immunol. 149: 139-145, 2007.
9. Munn DH, Zhou M, Attwood JT, et al: Prevention of allogeneic fetal rejection by tryptophan catabolism. Science 281: 1191-1193, 1998.
10. Kudo Y, Boyd CA, Spyropoulou I, et al: Indoleamine 2,3-dioxygenase: distribution and function in the developing human placenta. J Reprod Immunol 61: 87-98, 2004. (Pubitemid 38446982)
11. Munn DH, Sharma MD, Hou D, et al: Expression of indoleamine 2,3-dioxygenase by plasmacytoid dendritic cells in tumor-draining lymph nodes. J Clin Invest 114: 280-290, 2004. (Pubitemid 39071633)
12. Uyttenhove C, Pilotte L, Théate I, et al: Evidence for a tumoral immune resistance mechanism based on tryptophan degradation by indoleamine 2,3-dioxygenase. Nat Med 9: 1269-1274, 2003. (Pubitemid 37279849)
13. Lee JR, Dalton RR, Messina JL, et al: Pattern of recruitment of immunoregulatory antigen-presenting cells in malignant melanoma. Lab Invest 83: 1457-1466, 2003.
14. Nakanishi K, Yoshimoto T, Tsutsui H, Okamura H: Interleukin-18 regulates both Th1 and Th2 responses. Annu Rev Immunol 19: 423-474, 2001. (Pubitemid 32368042)
15. Huang X, Huang H, Dong M, Yao Q, Wang H: Serum and placental interleukin-18 are elevated in preeclampsia. J Reprod Immunol 65: 77-87, 2005. (Pubitemid 40193403)
16. Seol HJ, Lee ES, Jung SE, et al: Serum levels of YKL-40 and interleukin-18 and their relationship to disease severity in women with preeclampsia. J Reprod Immunol 79: 183-187, 2009.
17. Adams KM, Mandel LS, Guthrie KA, Atkinson MW: Interleukin-18 in the plasma of women with preeclampsia. Am J Obstet Gynecol 188: 1234-1237, 2003.
18. Roland L, Gagne A, Belanger MC, Boutet M, Julien P, Bilodeau JF: Plasma interleukin-18 (IL-18) levels are correlated with antioxidant vitamin coenzyme Q10 in preeclampsia. Acta Bestet Gynecol Scand 89: 360-366, 2010.
19. Liebau C, Baltzer AW, Schmidt S, et al: Interleukin-12 and interleukin-18 induce indoleamine 2,3-dioxygenase (IDO) activity in human osteosarcoma cell lines independently from interferon-gamma. Anticancer Res 22: 931-936, 2002. (Pubitemid 34475252)
20. Perry IJ and Beevers DG: The definition of pre-eclampsia. Br J Obstet Gynaecol 101: 587-591, 1994.
21. Kudo Y, Boyd CA, Sargent IL and Redman CW: Decreased tryptophan catabolism by placental indoleamine 2,3-dioxygenase in preeclampsia. Am J Obstet Gynecol 188: 719-726, 2003. (Pubitemid 36332440)
22. Brewster JA, Orsi NM, Gopichandran N, McShane P, Ekbote UV, Walker JJ: Gestational effects on host inflammatory response in normal and pre-eclamptic pregnancies. Eur J Obstet Gynecol Reprod Biol 140: 21-26, 2008.
23. Ekelund CK, Vogel I, Skogstrand K, et al: Interleukin-18 and interleukin-12 in maternal serum and spontaneous preterm delivery. J Reprod Immunol 77: 179-185, 2008. (Pubitemid 351335085)
24. De la Maza LM and Peterson EM. Dependence of the in vitro antiproliferative activity of recombinant human gamma-interferon on the concentration of tryptophan in culture media. Cancer Res 48: 346-350, 1988.
25. Bauer TM, Jiga LP, Chuang JJ, Randazzo M, Opelz G and Terness P. Studying the immunosuppressive role of indoleamine 2,3-dioxygenase: tryptophan metabolites suppress rat allogeneic T-cell responses in vitro and in vivo. Transpl Int 18: 95-100, 2005. (Pubitemid 41742952)
26. Mellor AL, Keskin DB, Johnson T, Chandler P and Munn DH: Cells expressing indoleamine 2,3-dioxygenase inhibit T cell responses. J Immunol 168: 3771-3776, 2002. (Pubitemid 34298376)
27. Nishizawa H, Hasegawa K, Suzuki M, et al: Mouse model for allogeneic immune reaction against fetus recapitulates human Preeclampsia. J Obstet Gynaecol Res 34: 1-6, 2008. (Pubitemid 351143713)
28. Fallarino F, Grohmann U, Hwang KW, et al: Modulation of tryptophan catabolism by regulatory T cells. Nat Immunol 4: 1206-1212, 2003. (Pubitemid 37547898)
29. Fallarino F, Grohmann U, You S, et al: The combined effects of tryptophan starvation and tryptophan catabolites down-regulate T cell receptor zeta-chain and induce a regulatory phenotype in naive T cells. J Immunol 176: 6752-6761, 2006. (Pubitemid 43787857)
30. Mouratidis PX and George AJ. Transfection of indoleamine 2,3 dioxygenase in primary endothelial cells. Methods Mol Biol 616: 149-159, 2010.
31. Hautz T, Brandacher G, Zeiger B, et al: Indoleamine 2,3-dioxygenase and foxp3 expression in skin rejection of human hand allografts. Transplant Proc 41: 509-512, 2009.